Mood Disorders Linked to the Reproductive Cycle in Women

Barbara L. Parry* and Patricia Haynes
Department of Psychiatry
University of California, San Diego
La Jolla, California 92093
tel: (619) 543-5592
fax: (619) 543-5462



REFERENCES

1.            Albers EH, Gerall AA, Axelson JF. Effect of reproductive state on circadian periodicity in the rat.  Physiol Behav 1981;26:21-25.

2.            Altshuler LL, Hendrick V, Parry B. Pharmacological management of premenstrual disorder. Harvard Rev Psychiatry 1995;2:233-245.

3.            Appleby L, Warner R, Whitton A, Faragher B. A controlled study of fluoxetine and cognitive-behavioural counselling in the treatment of postnatal depression. Br Med J (Clinical Research Ed.) 1997;314:932-936.

4.            Amino N, More H, Iwatani Y, et al. High prevalence of transient postpartum thyrotoxicosis and hypothyroidism.  N Engl J Med 1982;306:849-852.

5.            Austin MV, Mitchell PB. Use of psychotropic medications in breast-feeding women: acute and prophylactic treatment. Australian and New Zealand Journal of Psychiatry 1998;32:778-784.

6.            Axelson JF, Gerall AA, Albers E. Effect of progesterone on the estrous activity cycle of the rat.  Physiol Behav 1981;26:631-635.

7.            Baker ER, Best RG, Manfredi, RL, Demers LM, Wolf GC. Efficacy of progesterone vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. J of Assisted Reprod Gen 1995;12:205-209.

8.            Bancroft J, Boyle H, Warner P, Fraser HM.  The use of an LHRH agonist, buserelin, in the long term management of premenstrual syndromes.  Clin Endocrinol 1987;27:171-182.

9.            Berman KF, Schmidt PJ, Rubinow DR, Danaceau MA, Van Horn JD, Esposito G, Ostrem JL, Weinberger DR. Modulation of cognition-specific cortical activity by gonadal steroids: A positron-emission tomography study in women. Neurobiology 1997;94:8836-41.

10.        Brown CS, Ling FW, Andersen RN, Farmer RG, Arheart KL. Efficacy of depot leuprolide in premenstrual syndrome: Effect of symptom severity and type in a controlled trial. Obstet Gyn 1994;84:779-786.

11.        Brush MG, Watson SJ, Horrobin DF, Manku MS.  Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome.  Am J Obstet Gynecol 1984;150:363-366.

12.        Budoff PW.  The use of prostaglandin inhibitors for the premenstrual syndrome.  J Repro Med 1983;28:469-478.

13.        Callender K, McGregor M, Kirk P, Thomas CS.  A double-blind trial of evening primrose oil in the premenstrual syndrome: Nervous symptom subgroup.  Human Psychopharm 1988;3:57-61.

14.        Chang KD, Keck PE Jr., Stanton SP, McElroy SL, Strakowski SM, Geracioti TD Jr. Differences in thyroid function between bipolar manic and mixed states. Biol Psychiatry 1998;43:730-733.

15.        Cho JT, Bone S, Dunner DL, et al. The effects of lithium treatment on thyroid function in patients with primary affective disorder.  Am J  Psychiatry  1979;136:115-116.

16.        Chuong CJ, Coulam CB, Bergstralh EJ, O'Fallon WM, Steinmetz GI.  Clinical trial of naltrexone in premenstrual syndrome.  Obstet Gynecol 1988;72:332-336.

17.        Cohen L, Heller VL. On the use of anticonvulsants for manic depression during pregnancy. Psychosomatics 1990;31:462-464.

18.        Coryell W, Endicott J, Kuler M.  Rapid cycling affective disorder: Demographics, diagnosis, family history and course.  Arch Gen Psychiatry 1992;49:126-131.

19.        Cowdry RW, Wehr TA, Zis AP, Goodwin FK. Thyroid abnormalities associated with rapid cycling bipolar illness.  Arch Gen Psychiatry 1983;40:414-420.

20.        Dalton K. Progesterone, fluid and electrolytes in the premenstrual syndrome.  Br Med J 1980;281:1008-1009.

21.        Dalton K.  Progesterone prophylaxis used successfully in postnatal depression.  Practioner 1985;229:507-508.

22.        Dalton K. The Premenstrual Syndrome.  London: Heineman Medical;1964

23.        Dennerstein L, Spencer-Gardener C, Gotts G.  Progesterone and the premenstrual syndrome: A double-blind cross-over trial.  Br Med J 1985;290:1617-1621.

24.        Edwards JG, Anderson I. Systematic review and guide to selection of selective serotonin reuptake inhibitors. Drugs 1999; 57:507-33.

25.        Elsner CW, Buster JE, Schindler RA, Nessin SA, Abraham GE.  Bromocriptine treatment of premenstrual tension syndrome.  Obstet Gynecol 1980;56:723-726.

26.        Eriksson E, Hedberg MA, Andersch B, Sundblad C. The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmocology 1995;12:167-176.

27.        Facchinetti F, Borella P, Sances G, Fioroni L, Nappi RE, Genazzani AR.  Oral magnesium successfully relieves premenstrual mood changes.  Obstet Gynecol 1991;78:177-181.

28.        Freeman E, Rickels K, Sondheimer SJ, Polansky M.  Ineffectiveness of progesterone suppository treatment for premenstrual syndrome (see comments).  JAMA 1990;264:349-353.

29.        Freeman EW, Rickels K, Arredondo F, Kao L, Pollack SE, Sondheimer SJ. Full- or half-cycle treatment of severe premenstrual syndrom with a serotonergic antidepressant. J of Clin Psychopharmacology 1999;19:3-8.

30.        Freeman EW, Sondheimer SJ, Rickels K. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: A controlled study. Psychopharm Bull 1997;33:303-309.

31.        Garvey MJ, Tuason VB, Lumry AE, et al. Occurrence of depression in the postpartum state. J Affect Disord 1983;5:97-101.

32.        Giannini AJ, Sullivan B, Sarachene J, Loiselle RH.  Clonidine in the treatment of premenstrual syndrome: A subgroup study.  J Clin Psychiatry 1988;49:62-63.

33.        Glick ID, Stewart D.  A new drug treatment for premenstrual exacerbation of schizophrenia.  Compr Psychiatry 1980;21:281-287.

34.        Goodwin FK, Jamison KR. The natural course of manic depressive illness.  In Post RM, Ballenger JC  (eds):  Neurobiology of  Mood Disorders.  Baltimore/London: Williams and Wilkins;1984

35.        Gunston KD.  Premenstrual syndrome in Cape Town.  Part II.  A double-blind placebo-controlled study of the efficacy of mefenamic acid.  S Afr Med J 1986;70:159-160.

36.        Hagnell 0, Lanke J, Roisman B, et al. Are we entering an age of melancholy? Depressive illness and prospective epidemiological study over 25 years.  The Lundby Study, Sweden.  Psychol Med 1982;12:279-289.

37.        Hahn PM, Van Vugt DA, Reid RL. A randomized, placebo-controlled, crossover trial of danazol for the treatment of premenstrual syndrome. Psychoneuroendocrinology 1995; 20:193-209.

38.        Halbreich U. Role of estrogen in postmenopausal depression. Neurology 1997;48 (Suppl 7):S16-S20.

39.        Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychother Scand 1986;74:576.

40.        Halbreich U, Smoller JW. Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome. J Clin Psychiatry 1997;58:399-402.

41.        Halbreich U, Tworek H. Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int’l J Psychiatry Med 1993;23:1-27.

42.        Hammarback S, Backstrom T.  Induced anovulation as treatment of premenstrual tension syndrome.  Acta Obstet Gynecol Scand 1988;67:159-166.

43.        Harrison WM, Endicott J, Rabkin JG, Nee JC, Sandberg D.  Treatment of premenstrual dysphoria with alprazolam and placebo.  Psychopharmacol Bull 1987;23:150-153.

44.        Haskell SG, Richardson ED, Horwitz RI. The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature. J Clin Epidem 1997; 50:1249-1264.

45.        Hatotani N, Nomara J.  Neurobiology of Periodic Psychoses.  New York:Igaku-Shoin Toyko;1983.

46.        Hurd MW, Ralph MR. The significance of circadian organization for longevity in the golder hamster. J of Bio Rhythms 1998;13:430-436.

47.        Jakubowicz DL, Godard E, Dewhurst J.  The treatment of premenstrual tension with mefenamic acid: Analysis of prostaglandin concentrations.  Br J Obstet Gynaecol 1984; 91:78-84.

48.        Jansson R, Bernander S, Karlesson A, et al. Autoimmune thyroid depression in the postpartum period. J Clin Endocrinol Metab 1984;58:681-687.

49.        Jones DY.  Influence of dietary fat and on self-reported menstrual symptoms.  Physiol Behav 1987;40:483-487.

50.        Joseph-Vanderpool JR, Jacobsen FM, Murphy DL, Hill JL, Rosenthal NE. Seasonal variation in behavioral responses to m-CPP in patients with seasonal affective disorder and controls. Biological Psychiatry 1993;33:496-504.

51.        Kasper S, Sack DA, Wehr TA, et al. Nocturnal TSH and prolactin secretion during sleep deprivation and prediction of antidepressant  response  in  patients with major depression.  Biol Psychiatry 1988;24:631-641.

52.        Kendall DA, Stancel AM, Einna SJ. Imipramine: Effect of ovarian steroids on modification in serotonin receptor binding.  Science 1981;211:1183-1185.

53.        Kendell RE, Chalmers JC, Platz C. Epidemiology of puerperal psychoses.  Br J Psychiatry 1987;150:662-673.

54.        Klaiber EL, Broverman DM, Vogel W, et al. Estrogen therapy for severe persistent depressions in women.  Arch Gen Psychiatry 1979;36:550-554.

55.        Kraeplin E. Manic depressive insanity and paranoia. Edinburgh:Livingstone; 1921.

56.        Kukopulos A, Reginaldi P, Laddomada GF, et al: Course of the manic depressive cycle and changes caused by treatments.  Pharmacopsychiatry 1980;13:156-167.

57.        Kupfer DJ, Carpenter LL, Frank E. Possible role of antidepressants in precipitating mania and hypomania in recurrent  depression.  Am J Psychiatry 1988;145:804-808.

58.        Lam RW, Terman M, Wirz-Justice A. Light therapy for depressive disorders: Indications and efficacy. Mod Probl Pharmacopsychiatry 1997;25:215-34.

59.        Lazarus JH, Hall R, Othman S, Parkes AB, Richards CJ, McCulloch B, Harris B. The clinical spectrum of postpartum thyroid disease. QJM 1996;89:429-435.

60.        Maskall DD, Lam RW, Misri S, Carter D, Kuan AJ, Yatham LN, Athanasios PZ. Seasonality of symptoms in women with late luteal phase dysphoric disorder. Am J Psychiatry 1997;154:1436-1441.

61.        Meager I, Milgrom J. Group treatment for postpartum depression: A pilot study. Australian and New Zealand J of Psychiatry 1996;30:852-860.

62.        McEwen BS. Clinically-relevant basic science studies of gender differences and sex hormone effects, in press.

63.        McEwen BS, Parsons B. General steroid action on the brain: Neurochemistry and neuropharmacology.  Ann Rev Pharmacol Toxicol 1982;22:555-598.

64.        Mira M, McNeil D, Fraser IS, Vizzard J, Abraham S.  Mefenamic acid in the treatment of premenstrual syndrome.  Obstet Gynecol 1986;68:395-398.

65.        Morin LP, Fitzgerald KM, Zucker I. Estradiol shortens the period of hamster circadian rhythms.  Science 1977;196:305-306.

66.        Mortola JF, Girton L, Fischer U.  Successful treatment of severe premenstrual syndrome by combined use of gonadotropin-releasing horome agonist and estrogen/progesterone.  J Clin Endocrinol Metab 1991;72:252A-252F.

67.        Muse KN, Cetel NS, Futterman LA, Yen SSC.  The premenstrual syndrome: Effects of "medical ovariectomy."  N Engl J Med 1984;311:1345-1349.

68.        Neumeister A, Praschak-Rieder N, Hebelmann B, Rao M, Gluck J, Kasper S. Effects of tryptophan depletion on drug-free patients with seasonal affective disorder during a stable response to bright light therapy. Arch Gen Psych 1997;54:133-138.

69.        O'Brien PM, Craven D, Selby C, Symonds EM.  Treatment of premenstrual syndrome by spironolactone.  Br J Obstet Gynaecol 1979;86:142-147.

70.        Oppenheim G. A case of rapid mood cycling with estrogen: Implications for therapy. J Clin Psychiatry 1984;45:34-35.

71.        Parker DC, Rossman LG, Vanderloom EF. Sleep related, nyctohemeral and briefly episodic variation on human plasma prolactin concentrations.  J Clin Endocrinol Metab 1973;36:1119-1124.

72.        Parry BL, Berga SL, Kripke DF, Klauber MR, Laughlin GA, Yen SSC, Gillin JC. Altered waveform of plasma nocturnal melatonin secretion in premenstrual depression.  Arch Gen Psychiatry 1990;47:1139-1146.

73.        Parry BL, Berga SL, Mostofi N, Klauber MR, Resnick A. Plasma melatonin circadian rhythms during the menstrual cycle and after light therapy in premenstrual dysphoric disorder and normal control subjects. J Bio Rhythms 1997;12:47-64.

74.        Parry BL, Berga SL, Mostofi N, Sependa PA, Kripke DF, Gillin JC.  Morning vs. evening bright light treatment of late luteal phase dysphoric disorder.  Am J Psychiatry 1989; 146:1215-1217.

75.        Parry BL, Cover H, LeVeau B, et al. Early vs late partial sleep deprivation in premenstrual depression and normal control subjects. Am J Psychiatry 1995;152:404-412.

76.        Parry BL, Gerner RH, Wilkins JN et al. CSF and endocrine studies of premenstrual syndrome.  Neuropsychopharmacology 1991;5:127-137.

77.        Parry BL, Mahan AM, Mostofi N, Klauber MR, Lew GS, Gillin JC.  Light therapy of late luteal phase dysphoric disorder: An extended study.  Am J Psychiatry, 1993;150:1417-1419.

78.        Parry BL, Rosenthal NE, Tamarkin L, Wehr T. Treatment of a patient with seasonal premenstrual syndrome.  Am J Psychiatry 1987;144:762-766.   

79.        Parry BL, Rush AJ. Oral contraceptives and depressive symptomatology: Biologic mechanisms.  Compr Psychiatry 1979;20:347-358.

80.        Parry BL, Wehr TA. Therapeutic effect of sleep deprivation in patients with premenstrual syndrome.  Am J Psychiatry 1987;144:808-810.

81.        Post RM, Kramlinger KG, Joffe RT, Roy-Byrne PP, Rosoff A, Frye MA, Huggins T. Rapid cycling bipolar affective disorder: Lack of relation to hypothyroidism. Psychiatry Res 1997;72:1-7.

82.        Post RM, Rubinow DR, Ballenger JC. Conditioning, sensitization and kindling: Implications for the course of affective illness.  In Post RM, Ballenger JC (eds): Neurobiology of Mood Disorders.  Baltimore/London: Williams and Wilkins; 1984.

83.        Prange AJ, Wilson IC, Rabon AM, et al. Enhancement of imipramine antidepressant activity by thyroid hormone.  Am J Psychiatry 1969;126:457-469.

84.        Price WA, Dimarzio L. Premenstrual tension syndrome in rapid-cycling bipolar affective disorder. J Clin Psychiatry 1986;47:415-417.

85.        Puolakka J, Makarainen L, Viinikka L, Ylikorkala O.  Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors.  J Reprod Med 1985;30:149-153.

86.        Ramey JN, Burrow GN, Polackwich RJ, Donabedian RK. The effect of oral contraceptive steroids on the response of thyroid stimulating hormone to thyrotropin releasing hormone. J Clin Endocrinol Metab 1975;40:712-714.

87.        Reich T, Winokur G. Postpartum psychoses in patients with manic depressive disorder.  J Nerv Ment Dis 1970;151:60-68.

88.        Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Hormones and Behavior 1998; 34:171-82.

89.        Richter CP, Jones GS, Biswanger L. Periodic phenomena and the thyroid.  Arch  Neurol Psychiatry 1959;81:117-139.

90.        Rickles K, Freeman E, Sondheimer S.  Buspirone in treatment of premenstrual syndrome (letter).  Lancet 1989;1:777.

91.        Robins LN, Helzer JE, Weissman MM, et al. Lifetime prevalence of specific psychiatric disorders in three sites.  Arch Gen Psychiatry 1984;41:949-958.

92.        Rosenthal NE, Sack DA, James SP, Parry BL, Mendelson WB, Tamarkin L, Wehr TA. Seasonal affective disorder and phototherapy.  Ann NY Acad Sci 1985;453:260-269.

93.        Roy-Byrne PP, Uhde TW, Post RM. Effects of one nights sleep deprivation on mood and behavior in panic disorder.  Arch Gen Psychiatry 1986;43:895-900.

94.        Rubinow DR, Roy-Byrne P.  Premenstrual syndromes: Overview from a methodologic perspecitve.  Am J Psychiatry 1984;141:163-172.

95.        Sack DA, Duncan W, Rosenthal NE, et al. The timing and duration of sleep in partial sleep deprivation therapy of depression.  Acta Psychiatr Scand 1988;77:219-224.

96.        Sack DA, James SP, Rosenthal NE, et al. Deficient nocturnal surge of TSH secretion during sleep and sleep deprivation in rapid cycling bipolar illness.  Psychiatry Res 1988; 23:179-191.

97.        Sarno AP, Miller EJ, Lundblad EG.  Premenstrual syndrome: Beneficial effects of periodic, low-dose danazol.  Obstet Gynecol 1987;70:33-36.

98.        Schmidt PJ, Nieman LK, Danaceau MA, Adams LF, Rubinow DR. Differential behavioral effects of gonadal steriods in women with and in those without premenstrual syndrome. N Eng J Med 1998;338:209-216.

99.        Schmidt PJ, Nieman LK, Grover GN, Muller KL, Merriam GR, Rubinow DR. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Eng J Med 1991;324:1174-1179.

100.    Schou M. Treating recurrent affective disorders during and after pregnancy. Drug Safety 1998;18:143-152.

101.    Schwartz PJ, Murphy DL, Wehr TA, Garcia-Borreguero D, Oren D, Moul D, Ozaki N, Snelbaker AJ, Rosenthal NE. Effects of meta-chlorophenylpiperazine infusions in patients with Seasonal Affective Disorder and healthy control subjects. Arch Gen Psych 1997;54:375-385.

102.    Sherwin BB. Estrogenic effects on memory in women. Ann NY Acad of Sci 1994; 743:213-30.

103.    Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res 1994;644:305-312.

104.    Smith S, Rinehart JS, Ruddock VE, Schiff I.  Treatment of premenstrual syndrome with Alprazolam: Results of a double-blind, placebo-controlled, randomized crossover clinical trial.  Obstet Gynecol 1987;70:37-43.

105.    Spinelli MG. Interpersonal psychotherapy for depressed antepartum women: A pilot study. Am J Psychiatry 1997;154:1028-1030.

106.    Spitz IM, Zylber-Haran A, Trestian S. The thyrotropin (TSH) profile in isolated gonadotropin deficiency: A model to evaluate the effect of sex steroids on TSH secretion. J Clin Endocrinol Metab 1983;57:425-430.

107.    Stancer HC, Persad E. Treatment of intractable rapid cycling manic depressive disorder with levothyroxine.  Arch Gen Psychiatry 1982;39:311-312.

108.    Steiner M, Korzekwa M, Lamont J, Wilkins A. Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria. Psychopharm Bull 1997;33:771-774.

109.    Steiner M, Steinberg S, Stewart D, Carter D, Berger C, et al. N Eng J of Med 1995;332: 1529-1534.

110.    Suhail K, Cochrane R. Seasonal variations in hospital admissions for affective disorders by gender and ethnicity. Soc Psychiatry Psychiatr Epidem 1988;33:211-217.

111.    Tam LW, Parry BL. New findings in the treatment of depression at menopause. Submitted for publication, 1998.

112.    Thomas EMV, Armstrong SM. Effect of ovariectomy and estradiol on unity of female rat circadian rhythms. Am J Physiol 1989;257:R1241-1250.

113.    Tondo L, Baldessarini RJ. Rapid cycling in women and men with bipolar manic-depressive disorders. Am J Psychiatry 1998;155:1434-1436.

114.    Transbol I, Christiansen C, Baastrup PC. Endocrine effects of lithium.  Acta Endocrinol 978;87:759-767.

115.    Trixler M, Tenyi T. Antipsychotic use in pregnancy. What are the best treatment options? Drug Safety 1997;16:403-10.

116.    Vellacott ID, Shroff NE, Pearce MY, Stratford ME, Akbar FA.  A double-blind placebo evaluation of spironolactone in the premenstrual syndrome.  Curr Med Res Opin 1987; 10:450-456.

117.    Videbech P, Gouliaev G. First admission with puerperal psychosis: 7-14 years of follow-up. Acta Psychiatr Scand 1995;91:167-173.

118.    Warner R, Appleby L, Whitton A, Faragher B. Demographic and obstetric risk factors for postnatal psychiatric morbidity. Brit J Psychiatry 1996;168:607-611.

119.    Watts JF, Butt WR, Logan Edwards R.  A clinical trial using danazol for the treatment of premenstrual tension.  Br J Obstet Gynecol 1987;94:30-34.

120.    Wehr TA, Goodwin FK. Rapid cycling in manic depressives induced by tricyclic antidepressants.  Arch Gen Psychiatry 1979;36:555-559.

121.    Wehr TA, Sack DA, Jacobsen FM, et al. Phototherapy of seasonal affective disorder: Time of day and suppression of melatonin are not critical for antidepressant effects.  Arch Gen Psychiatry 1986;43:870-875.

122.    Wehr TA, Sack DA, Rosenthal NE.  Rapid cycling affective disorder: Contributing factors and treatment responses of 51 patients.  Am J Psychiatry 1988;145:179-184.

123.    Wehr TA, Sack DA, Rosenthal NE.  Seasonal affective disorder with summer depression and winter hypomania.  Am J Psychiatry 1987;144:1602-1603.

124.    Wehr TA, Sack DA, Rosenthal NE.  Sleep reduction as a final common pathway in the genesis of mania.  Am J Psychiatry 1987;144:201-204.

125.    Weissman MM, Gammon D, John K, et al. Children of depressed parents: Increased psychopathology and early onset of major depression.  Arch Gen Psychiatry 1987;44:847-53.

126.    Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;34:98-111.

127.    Weissman MM, Leaf PJ, Holzer CE, et al. The epidemiology of depression: An update on sex differences in rates.  J Affect Disord 1984;7:179-188.

128.    Werch A, Kane RE.  Treatment of premenstrual tension with metolazone: A double-blind evaluation of a new diuretic.  Curr Therapeutic Res. 1976;19:565-572.

129.    West CP, Hillier H. Ovarian suppression with the gonadotrophin-releasing hormone agonist goserelin (Zoladex) in management of the premenstrual tension syndrome. Human Reproduction 1994;9:1058-1063.

130.    Wever RA. Properties of human sleep-wake cycles: Parameters of internally synchronized free running rhythms.  Sleep 1984;7:27-51.

131.    Whybrow PC, Prange AJ. A hypothesis of thyroid-catecholamine receptor interaction.  Arch Gen Psychiatry 1981;38:106-113.

132.    Williams MJ, Harris RI, Dean BC.  Controlled trial of pyridoxine in the premenstrual syndrome.  J Int Med Res 1985;13:174-179.

133.    Wirz-Justice A, Wever RA, Aschoff J. Seasonality in freerunning rhythms in man. Naturwissenschaften 1984;71:316-319.

134.    Wise PM, Krajnak KM, Kashon ML. Menopause: The aging of multiple pacemakers. Science 1996;273:67-70.

135.    Wisner KL, Perel JM. Serum levels of valproate and carbamazepine in breastfeeding mother-infant pairs. J Clin Psychopharm 1998;18:167-169.

136.    Wisner KL, Perel JM, Findling RL. Antidepressant treatment during breast-feeding. Am J of Psychiatry 1996;153:1132-1137.

137.    Wood C, Jakubowicz D.  The treatment of premenstrual symptoms with mefenamic acid.  Br. J. Obstet Gynaecol 1980;87:627-630.

138.    Ylostalo P, Kauppila A, Puolakka J, Ronnberg L Janne O.  Bromocriptine and norethisterone in the treatment of premenstrual yndrome.  Obstet Gynecol 1982;59:292-98.

139.    Yonkers KA, Gullion C, Williams A, Novak K, Rush AJ. Paroxetine as a treatment for premenstrual dysphoric disorder. J of Clin Psychopharm 1996;16:3-8.

140.    Yonkers KA, Halbreich U, Freeman E, Brown C, Endicott J et al. Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment: A randomized controlled trial. JAMA 1997;278:983-988.

141.    Yonkers KA, White K.  Premenstrual exacerbation of depression: one process or two?  J Clin Psychiatry 1992;53:289-292.

142.    Young SA, Hurt PH, Benedek DM, Howard RS. Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: A randomized, double-blind, placebo-controlled crossover trial. J Clin Psychiatry 1998;59:76-79.

143.    Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.

 
Back to Chapter

published 2000